Cheng Zhan

5.5k total citations · 2 hit papers
212 papers, 3.5k citations indexed

About

Cheng Zhan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Cheng Zhan has authored 212 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 82 papers in Molecular Biology and 59 papers in Oncology. Recurrent topics in Cheng Zhan's work include Lung Cancer Treatments and Mutations (54 papers), Lung Cancer Diagnosis and Treatment (47 papers) and RNA modifications and cancer (41 papers). Cheng Zhan is often cited by papers focused on Lung Cancer Treatments and Mutations (54 papers), Lung Cancer Diagnosis and Treatment (47 papers) and RNA modifications and cancer (41 papers). Cheng Zhan collaborates with scholars based in China, United States and United Kingdom. Cheng Zhan's co-authors include Qun Wang, Yiwei Huang, Mengnan Zhao, Tao Lu, Ming Li, Xiaodong Yang, Jiaqi Liang, Yu Shi, Zhencong Chen and Wei Jiang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Cheng Zhan

197 papers receiving 3.5k citations

Hit Papers

<p>Trends in the incidence, treatment, and survival... 2019 2026 2021 2023 2019 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Zhan China 31 1.6k 1.6k 1.0k 975 418 212 3.5k
Giuseppe Luigi Banna Italy 33 1.3k 0.8× 1.2k 0.7× 574 0.6× 2.1k 2.2× 459 1.1× 164 3.9k
Tong Zhang China 29 2.1k 1.3× 1.5k 0.9× 1.1k 1.1× 1.8k 1.9× 364 0.9× 162 4.5k
Edward Gabrielson United States 31 965 0.6× 1.6k 1.0× 1.0k 1.0× 1.0k 1.1× 246 0.6× 59 3.4k
Zhijie Wang China 33 1.9k 1.2× 999 0.6× 961 0.9× 2.3k 2.3× 307 0.7× 177 3.8k
Yinghao Sun China 40 1.4k 0.9× 2.5k 1.5× 1.8k 1.7× 580 0.6× 728 1.7× 167 4.7k
Akira Saito Japan 33 814 0.5× 1.9k 1.1× 577 0.6× 836 0.9× 473 1.1× 203 4.3k
Pernilla Wikström Sweden 38 1.9k 1.2× 2.3k 1.4× 1.3k 1.2× 1.1k 1.1× 249 0.6× 105 4.5k
Wei Guo China 35 824 0.5× 2.3k 1.4× 1.1k 1.0× 1.2k 1.3× 403 1.0× 174 4.2k
Toshiyuki Kamoto Japan 37 1.6k 1.0× 1.4k 0.9× 602 0.6× 840 0.9× 788 1.9× 262 3.9k
Teresa A. Goldin United States 4 1.2k 0.7× 2.1k 1.3× 1.3k 1.2× 1.9k 1.9× 730 1.7× 5 4.7k

Countries citing papers authored by Cheng Zhan

Since Specialization
Citations

This map shows the geographic impact of Cheng Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Zhan more than expected).

Fields of papers citing papers by Cheng Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Zhan. The network helps show where Cheng Zhan may publish in the future.

Co-authorship network of co-authors of Cheng Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Zhan. A scholar is included among the top collaborators of Cheng Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Zhan. Cheng Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Jiaqi, Guoshu Bi, Xiaolong Huang, et al.. (2025). CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer. Cancer Communications. 45(11). 1547–1578.
2.
Bi, Guoshu, Jiaqi Liang, Yunyi Bian, et al.. (2025). Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC. Nature Communications. 16(1). 8181–8181. 1 indexed citations
3.
Zhang, Yuanyuan, Cheng Zhan, Mei Long, et al.. (2025). Silencing of lncRNA Gm26917 Attenuates Alveolar Macrophage-mediated Inflammatory Response in LPS-induced Acute Lung Injury Via Inhibiting NKRF Ubiquitination. Inflammation. 48(5). 2924–2941. 1 indexed citations
4.
Bian, Yunyi, Guangyao Shan, Guoshu Bi, et al.. (2025). Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status. Nature Communications. 16(1). 9923–9923.
5.
Liu, Shuang, Qian Yu, Zhiwei Guo, et al.. (2025). Targeting IRG1 in tumor-associated macrophages for cancer therapy. Protein & Cell. 16(6). 478–483.
6.
Marcadet, Laetitia, Cheng Zhan, John W. Kennedy, et al.. (2025). Targeting lipid droplets in FUS-linked amyotrophic lateral sclerosis mitigates neuronal and astrocytic lipotoxicity. Brain. 149(2). 472–488.
7.
Hu, Zhongbo, Shishu Zhang, Qinke Wang, Guoliang Zhao, & Cheng Zhan. (2024). Vertical bearing performance of a concrete-filled steel tubular single pile and pile group in sand-rock composite ground. Applied Ocean Research. 154. 104371–104371.
8.
Shan, Guangyao, Yunyi Bian, Guangyu Yao, et al.. (2024). Targeting ALDH2 to augment platinum-based chemosensitivity through ferroptosis in lung adenocarcinoma. Free Radical Biology and Medicine. 224. 310–324. 8 indexed citations
9.
Yang, Dawei, Yan Li, Qiushi Li, et al.. (2024). All-in-one multiple extracellular vesicle miRNA detection on a miniaturized digital microfluidic workstation. Biosensors and Bioelectronics. 270. 116976–116976. 6 indexed citations
10.
Bi, Guoshu, Jiaqi Liang, Guangyao Shan, et al.. (2023). Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells. Cancer Research. 83(14). 2387–2404. 37 indexed citations
11.
Yu, Kaiwen, et al.. (2023). Genome-wide analyses of lung cancer after single high-dose radiation at five time points (2, 6, 12, 24, and 48 h). Frontiers in Genetics. 14. 1126236–1126236. 1 indexed citations
12.
Hu, Zhengyang, Xing Jin, Weifeng Hong, et al.. (2023). Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. Cellular Oncology. 46(5). 1351–1368. 13 indexed citations
13.
Song, Yi, et al.. (2023). Green Eco-Innovation and Supply of Critical Metals: Evidence from China. Sustainability. 15(17). 12730–12730. 2 indexed citations
14.
Jiang, Tao, Min Li, Lin Miao, et al.. (2019). Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification. SHILAP Revista de lepidopterología.
15.
Yang, Xue‐Ning, Yongsheng Huang, Meng Zhao, et al.. (2019). Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. SHILAP Revista de lepidopterología. 31 indexed citations
16.
Xia, Yifeng, Cheng Zhan, Mingxiang Feng, et al.. (2018). Targeting CREB Pathway Suppresses Small Cell Lung Cancer. Molecular Cancer Research. 16(5). 825–832. 37 indexed citations
17.
Zhang, Longwa, et al.. (2016). Evaluation of Beauveria bassiana isolates as potential agents for control of Hyphantria cunea (Lepidoptera: Arctiidae).. Acta Entomologica Sinica. 59(1). 111–118. 7 indexed citations
18.
Zhan, Cheng, et al.. (2013). Fast Detection of Specific DNA by Liquid Hybridization. Zhongguo shengwu gongcheng zazhi. 33(7). 64–70. 1 indexed citations
19.
Zhan, Cheng. (2008). Analysis on the Factors of Further Diversification of Post-war American Culture and its Impact on the Development of American Society.
20.
Zhan, Cheng. (2003). A comparative study on the efficacy and safety of intravenous amiodarone and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart falure. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026